Indication

Heterotopic ossification

Heterotopic ossification is a musculoskeletal pathology characterized by the abnormal formation of mature, lamellar bone within extraskeletal soft tissues such as skeletal muscle, tendons, and ligaments where bone does not normally exist. Read more about Heterotopic ossification

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Heterotopic ossification therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Heterotopic ossification preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Heterotopic ossification.

Heterotopic ossification is a musculoskeletal pathology characterized by the abnormal formation of mature, lamellar bone within extraskeletal soft tissues such as skeletal muscle, tendons, and ligaments where bone does not normally exist.

It most commonly develops as an acquired complication following significant musculoskeletal trauma, orthopedic surgery, severe burns, or central nervous system injuries like traumatic brain injury and spinal cord trauma.

Pathophysiologically driven by an inappropriate osteogenic differentiation of mesenchymal progenitor cells often spurred by local inflammation, the condition typically presents with localized pain, swelling, erythema, progressive joint stiffness, and a decreased range of motion that can advance to complete joint ankylosis.

Personalize your experience

Follow Heterotopic ossification and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it